About this trial
To carry out an assessment of compliance and quality of life in a population (children and adults) with DDB before and after the use of an oscillating PEP. The aim is to determine the impact of the use of oscillating PEP on the daily life of this population in particular.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Children (from 8 years of age) and adults over 18 years of age with DDB who doesn't use oscillating PEP.
Disqualifiers
Children under 8 years of age.
Patients who use an OPEP
Patients in the acute exacerbation phase of their DDB
Patients who are not under regular consultation
Trial design
Parallel
Treatments tested in this trial
adult questionnary for parents of children aged 8 to 13
Other interventionQuality of life questionnaire for parents of children aged 8 to 13
Quality of life questionnaire for children aged 8 to 13
Other interventionQuality of life questionnaire for children aged 8 to 13
Quality of life questionnaire for adolescents aged 14 to 17
Other interventionQuality of life questionnaire for adolescents aged 14 to 17
Quality of life questionnaire for adults
Other interventionQuality of life questionnaire for adults
A satisfaction adherence questionnaire
Other interventionA satisfaction adherence questionnaire will also be distributed to patients after several months' use of oscillating PEP
Treatment groups
Trial outcomes
Primary outcomes
Variation of patient quality of life before and after OPEP installation
quality of life is determined by qustionnaire
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Centre Hospitalier Universitaire, Amiens
Lead sponsor
Hôpital Armand Trousseau
Collaborator